Research at Joslin Diabetes Center
Pilot & Feasibility Studies
As part of the NIH grant that supports Joslin Diabetes Center’s Diabetes Research Center (DRC), the Pilot & Feasibility Program offers funding for two studies in the areas of Type-1 diabetes, Type-2 diabetes or their complications from basic, translational or clinical research perspectives.
News | Joslin Research
The 285 scientists at Joslin are dedicated to pursuing innovative pathways of discovery to prevent, treat and cure type 1 and type 2 diabetes and their complications.
We are especially excited about Joslin’s three-lab collaboration to Reset, Regulate and Regenerate the immune system. We feel Joslin is unique in this “3Rs” approach to achieve a permanent cure to diabetes:
- Reset the immune system to get rid of the T Cells that cause Type 1 diabetes.
- Regulate the immune system so that it doesn’t attack the beta cells
- Regenerate beta cells
The Cortex Application Suite contains:
- Advanced Genomics/Genetics Core
- Advanced Microscopy Core (EM and Histology)
- Animal Physiology Core
- Bioinformatics Core
- Flow Cytometry Core
- iPS Core
- Media Core
- Specialized Assay Core